No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference
Radiopharm Theranostics Price Target Announced at $12.00/Share by Maxim Group
Radiopharm Theranostics Advances in Clinical Trials and Secures Major Investment
Radiopharm Theranostics Doses First Patient In U.S. Phase 2B Imaging Study Of 18F-RAD101 In Suspected Recurrent Brain Metastasis
Top Premarket Decliners
12 Health Care Stocks Moving In Monday's After-Market Session